There are 302 resources available
228P - Modulating mitochondrial dynamics in TAMs to enhance anti-tumor immunity
Presenter: Pu-ste Liu
Session: Poster Display session
Resources:
Abstract
229P - Investigation of the effects of long-noncoding RNA NRAV on interferon response in melanoma
Presenter: Kadir Durmus
Session: Poster Display session
230P - Deciphering the mechanism of immunosuppressive activity of acetaminophen in the context of cancer immunotherapy
Presenter: Jeanne Lena
Session: Poster Display session
231P - The impact of calcitriol and tacalcitol on the Th17 lymphocytes in breast cancer
Presenter: Beata Filip-Psurska
Session: Poster Display session
Introduction to the Keynote Speaker
Presenter: Inge Marie Svane
Session: Keynote address: Neoadjuvant CPI
Resources:
Slides
Webcast
Epigenetic heritability of cell plasticity in cancer drug resistance
Presenter: Alejandra Bruna
Session: Epigenetics
Resources:
Slides
Webcast
LBA2 - SKYSCRAPER-06: Efficacy and safety of tiragolumab plus atezolizumab plus chemotherapy (tira + atezo + chemo) vs pembrolizumab plus chemotherapy (pembro + chemo) in patients (pts) with advanced non-squamous non-small cell lung cancer (NSq NSCLC)
Presenter: Mark Socinski
Session: Mini Oral session 2
Resources:
Abstract
Cell therapy targeting antigens resulting from tryptophan depletion
Presenter: Reuven Agami
Session: Primary IO refractory cancers
Resources:
Slides
Webcast
Invited Discussant LBA2, LBA3, 118MO and 66MO
Presenter: Marcello Tiseo
Session: Mini Oral session 2
Resources:
Slides
Webcast
GDF-15: A cytokine involved in IO escape?
Presenter: Elena Garralda
Session: Primary IO refractory cancers
Resources:
Slides
Webcast